Search research articles
Contact Us
Filters
Showing results (311-320 of 331) with videos related to
Page
of 34
Sort By:
Schizophrenia Research
|
November 25, 2015
Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study
Tiffany A Greenwood, Laura C Lazzeroni, Monica E Calkins, et al.
Schizophrenia Research
|
January 11, 2014
Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS
Neal R Swerdlow, Gregory A Light, Joyce Sprock, et al.
Schizophrenia Research
|
October 13, 2014
The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2
Bruce I Turetsky, Erich M Dress, David L Braff, et al.
JAMA Psychiatry
|
October 10, 2019
Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) Study
Tiffany A Greenwood, Laura C Lazzeroni, Adam X Maihofer, et al.
Schizophrenia Research
|
May 28, 2017
Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension
Neal R Swerdlow, Gregory A Light, Michael L Thomas, et al.
Schizophrenia Bulletin
|
June 7, 2014
Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study
Gregory Light, Tiffany A Greenwood, Neal R Swerdlow, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 11, 2025
Post-COPD: Can Emphysema Be Repaired?
J Michael Wells, Jerry A Krishnan, R Chad Wade, et al.
The American Journal of Psychiatry
|
May 14, 2021
Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia
Yash B Joshi, Michael L Thomas, David L Braff, et al.
Schizophrenia Research
|
December 3, 2014
Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2
Gregory A Light, Neal R Swerdlow, Michael L Thomas, et al.
Schizophrenia Research
|
December 16, 2014
California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS)
William S Stone, Raquelle I Mesholam-Gately, David L Braff, et al.
Page
of 34
Search research articles
Search
Showing results (311-320 of 331) with videos related to
Sort By:
Page
of 34
Schizophrenia Research
|
November 25, 2015
Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study
Tiffany A Greenwood, Laura C Lazzeroni, Monica E Calkins, et al.
Schizophrenia Research
|
January 11, 2014
Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS
Neal R Swerdlow, Gregory A Light, Joyce Sprock, et al.
Schizophrenia Research
|
October 13, 2014
The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2
Bruce I Turetsky, Erich M Dress, David L Braff, et al.
JAMA Psychiatry
|
October 10, 2019
Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) Study
Tiffany A Greenwood, Laura C Lazzeroni, Adam X Maihofer, et al.
Schizophrenia Research
|
May 28, 2017
Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension
Neal R Swerdlow, Gregory A Light, Michael L Thomas, et al.
Schizophrenia Bulletin
|
June 7, 2014
Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study
Gregory Light, Tiffany A Greenwood, Neal R Swerdlow, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 11, 2025
Post-COPD: Can Emphysema Be Repaired?
J Michael Wells, Jerry A Krishnan, R Chad Wade, et al.
The American Journal of Psychiatry
|
May 14, 2021
Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia
Yash B Joshi, Michael L Thomas, David L Braff, et al.
Schizophrenia Research
|
December 3, 2014
Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2
Gregory A Light, Neal R Swerdlow, Michael L Thomas, et al.
Schizophrenia Research
|
December 16, 2014
California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS)
William S Stone, Raquelle I Mesholam-Gately, David L Braff, et al.
Page
of 34